The paradox of the unfolded protein response in cancer

Anticancer Research

Volumn 33, Issue 11, 2013, Pages 4683-4694

  Vandewynckel, Yves Paul ^a   Laukens, Debby ^a   Geerts, Anja ^a   Bogaerts, Eliene ^a   Paridaens, Annelies ^a   Verhelst, Xavier ^a   Janssens, Sophie ^c,d   Heindryckx, Femke ^b   Van Vlierberghe, Hans ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UPPSALA UNIVERSITY   (Sweden)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Activating transcription factor 6; Cancer; Endoplasmic reticulum; Inositol requiring enzyme 1; Molecular chaperones; PERK kinase; Review; Stress; Unfolded protein response

Indexed keywords

GLUCOSE REGULATED PROTEIN 78;

APOPTOSIS; CARCINOGENESIS; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; REVIEW; SUICIDE GENE; SURFACE PROPERTY; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE;

ACTIVATING TRANSCRIPTION FACTOR 6; CANCER; ENDOPLASMIC RETICULUM; INOSITOL REQUIRING ENZYME-1; MOLECULAR CHAPERONES; PERK KINASE; REVIEW; STRESS; UNFOLDED PROTEIN RESPONSE;

ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM STRESS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; UNFOLDED PROTEIN RESPONSE;

EID: 84891355594     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Wang M, Wey S, Zhang Y, Ye R and Lee AS: Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal 11: 2307-2316, 2009.
2. Stolz A and Wolf DH: Endoplasmic reticulum associated protein degradation: A chaperone assisted journey to hell. Biochim Biophys Acta 1803: 694-705, 2010.
3. Kozutsumi Y, Segal M, Normington K, Gething MJ and Sambrook J: The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332: 462-464, 1988.
4. Walter P and Ron D: The unfolded protein response: From stress pathway to homeostatic regulation. Science 334: 1081-1086, 2011.
5. Hetz C, Martinon F, Rodriguez D and Glimcher LH: The unfolded protein response: Integrating stress signals through the stress sensor IRE1α. Physiol Rev 91: 1219-1243, 2011.
6. Chakrabarti A, Chen AW and Varner JC: A review of the mammalian unfolded protein response. Biotechnol Bioeng 108: 2777-2793, 2011.
7. Dong D, Stapleton C, Luo B, Xiong S, Ye W, Zhang Y, Jhaveri N, Zhu G, Ye R, Liu Z, Bruhn KW, Craft N, Groshen S, Hofman FM and Lee AS: A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res 71: 2848-2857, 2011.
8. Mahadevan NR and Zanetti M: Tumor stress inside out: Cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment. J Immunol 187: 4403-4409, 2011.
9. Tagliavacca L, Caretti A, Bianciardi P and Samaja M: In vivo up-regulation of the unfolded protein response after hypoxia. Biochim Biophys Acta 1820: 900-906, 2012.
10. Queitsch C, Sangster TA and Lindquist S: Hsp90 as a capacitor of phenotypic variation. Nature 417: 618-624, 2002.
11. Spiotto MT, Banh A, Papandreou I, Cao H, Galvez MG, Gurtner GC, Denko NC, Le QT and Koong AC: Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth. Cancer Res 70: 78-88, 2010.
12. Appenzeller-Herzog C and Hall MN: Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol 22: 274-282, 2012.
13. Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, Harding H, Novoa I, Varia M, Raleigh J, Scheuner D, Kaufman RJ, Bell J, Ron D, Wouters BG and Koumenis C: ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 24: 3470-3481, 2005.
14. Li Z and Li Z: Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks. Biochim Biophys Acta 1826: 13-22, 2012.
15. Fels DR and Koumenis C: The PERK/eIF2α/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther 5: 723-728, 2006.
16. Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, Cavener D and Diehl JA: PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene 29: 3881-3895, 2010.
17. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, Le QT and Koong AC: XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res 64: 5943-5947, 2004.
18. Amann T and Hellerbrand C: GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 13: 1411- 1427, 2009.
19. Ryder CB, McColl K and Distelhorst CW: Acidosis blocks CCAAT/enhancer-binding protein homologous protein (CHOP)-and c-Jun-mediated induction of p53-up-regulated mediator of apoptosis (PUMA) during amino acid starvation. Biochem Biophys Res Commun 430: 1283-1288, 2013.
20. Shiu RP, Pouyssegur J and Pastan I: Glucose depletion accounts for the induction of two transformation-sensitive membrane proteinsin Rous sarcoma virus-transformed chick embryo fibroblasts. Proc Natl Acad Sci USA 74: 3840-3844, 1977.
21. Huber AL, Lebeau J, Guillaumot P, Pétrilli V, Malek M, Chilloux J, Fauvet F, Payen L, Kfoury A, Renno T, Chevet E and Manié SN: p58(IPK)-Mediated attenuation of the proapoptotic PERKCHOP pathway allows malignant progression upon low glucose. Mol Cell 49: 1049-1059, 2013.
22. Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell 144: 646-674, 2011.
23. Fu Y, Wey S, Wang M, Ye R, Liao CP, Roy-Burman P and Lee AS: Pten null prostate tumorigenesis and PKB activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc Natl Acad Sci USA 105: 19444-19449, 2008.
24. Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC, Donia M, Fagone P, Malaponte G, Nicoletti F, Libra M, Milella M, Tafuri A, Bonati A, Bäsecke J, Cocco L, Evangelisti C, Martelli AM, Montalto G, Cervello M and McCubrey JA: Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 3: 192-222, 2011.
25. Jamora C, Dennert G and Lee AS: Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc Natl Acad Sci USA 93: 7690-7694, 1996.
26. Dong D, Ni M, Li J, Xiong S, Ye W, Virrey JJ, Mao C, Ye R, Wang M, Pen L, Dubeau L, Groshen S, Hofman FM and Lee AS: Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 68: 498-505, 2008.
27. Pyrko P, Schönthal AH, Hofman FM, Chen TC and Lee AS: The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res 67: 9809-9816, 2007.
28. Shuda M: Activation of the ATF6, XBP1 and GRP78 genes in human hepatocellular carcinoma: A possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38: 605-614, 2003.
29. So AYL, de la Fuente E, Walter P, Shuman M and Bernales S: The unfolded protein response during prostate cancer development. Cancer Metastasis Rev 28: 219-223, 2009.
30. Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen CR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, Kaufman RJ, Bastian BC and Soengas MS: Antioncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 8: 1053-1063, 2006.
31. Luo B and Lee AS: The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene 32: 805-818, 2012.
32. Kern J, Untergasser G, Zenzmaier C, Sarg B, Gastl G, Gunsilius E and Steurer M: GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib. Blood 114: 3960-3967, 2009.
33. Nagaoka T, Karasawa H, Castro NP, Rangel MC, Salomon DS and Bianco C: An evolving web of signaling networks regulated by Cripto-1. Growth Factors 30: 13-21, 2012.
34. Nakamura S, Takizawa H, Shimazawa M, Hashimoto Y, Sugitani S, Tsuruma K and Hara H: Mild endoplasmic reticulum stress promotes retinal neovascularization via induction of BiP/GRP78. PloS One 8: e60517, 2013.
35. Ghosh R, Lipson KL, Sargent KE, Mercurio AM, Hunt JS, Ron D and Urano F: Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PloS One 5: e9575, 2010.
36. Chang KC, Chen PCH, Chen YP, Chang Y and Su IJ: Dominant expression of survival signals of endoplasmic reticulum stress response in Hodgkin lymphoma. Cancer Sci 102: 275-281, 2011.
37. Schewe DM and Aguirre-Ghiso JA: ATF6α-RHEB-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc Natl Acad Sci USA 105: 10519-10524, 2008.
38. Shoulders MD, Ryno LM, Genereux JC, Moresco JJ, Tu PG, Wu C, Yates JR, Su AI, Kelly JW and Wiseman RL: Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep 3: 1279-1292, 2013.
39. Adachi Y, Yamamoto K, Okada T, Yoshida H, Harada A and Mori K: ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum. Cell Struct Funct 33: 75-89, 2008.
40. Han D, Lerner AG, Vande Walle L, Upton JP, Xu W, Hagen A, Backes BJ, Oakes SA and Papa FR: IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell 138: 562-575, 2009.
41. Maestre L, Tooze R, Cañamero M, Montes-Moreno S, Ramos R, Doody G, Boll M, Barrans S, Baena S, Piris MA and Roncador G: Expression pattern of XBP1(S) in human B-cell lymphomas. Haematologica 94: 419-422, 2009.
42. Fujimoto T, Yoshimatsu K, Watanabe K, Yokomizo H, Otani T, Matsumoto A, Osawa G, Onda M and Ogawa K: Overexpression of human X-box binding protein 1 (XBP-1) in colorectal adenomas and adenocarcinomas. Anticancer Res 27: 127-131, 2007.
43. Davies MPA, Barraclough DL, Stewart C, Joyce KA, Eccles RM, Barraclough R, Rudland PS and Sibson DR: Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer. Int J Cancer 123: 85-88, 2008.
44. Thorpe JA and Schwarze SR: IRE1alpha controls cyclin A1 expression and promotes cell proliferation through XBP-1. Cell Stress Chaperones 15: 497-508, 2010.
45. Zhong Y, Li J, Wang JJ, Chen CC, Tran JTA, Saadi A, Yu Q, Le YZ, Mandal MNA, Anderson RE and Zhang SX: X-box binding protein 1 is essential for the anti-oxidant defense and cell survival in the retinal pigment epithelium. PloS One 7: e38616, 2012.
46. Carrasco DR, Sukhdeo K, Protopopova M, Sinha R, Enos M, Carrasco DE, Zheng M, Mani M, Henderson J, Pinkus GS, Munshi N, Horner J, Ivanova EV, Protopopov A, Anderson KC, Tonon G and DePinho RA: The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell 11: 349-360, 2007.
47. Papandreou I, Denko NC, Olson M, Van Melckebeke H, Lust S, Tam A, Solow-Cordero DE, Bouley DM, Offner F, Niwa M and Koong AC: Identification of an IRE1α endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood 117: 1311-1314, 2011.
48. Auf G, Jabouille A, Guérit S, Pineau R, Delugin M, Bouchecareilh M, Magnin N, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A and Moenner M: Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci USA 107: 15553-15558, 2010.
49. Drogat B, Auguste P, Nguyen DT, Bouchecareilh M, Pineau R, Nalbantoglu J, Kaufman RJ, Chevet E, Bikfalvi A and Moenner M: IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res 67: 6700-6707, 2007.
50. Romero-Ramirez L, Cao H, Regalado MP, Kambham N, Siemann D, Kim JJ, Le QT and Koong AC: X-Box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas. Transl Oncol 2: 31-38, 2009.
51. Zeng L, Xiao Q, Chen M, Margariti A, Martin D, Ivetic A, Xu H, Mason J, Wang W, Cockerill G, Mori K, Li JY, Chien S, Hu Y and Xu Q: Vascular endothelial cell growth-activated XBP1 splicing in endothelial cells is crucial for angiogenesis. Circulation 127: 1712-1722, 2013.
52. Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayama T and Tohyama M: Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem 276: 13935-13940, 2001.
53. Jing G, Wang JJ and Zhang SX: ER stress and apoptosis: A new mechanism for retinal cell death. Exp Diabetes Res 2012: 589589, 2012.
54. Gomez BP, Riggins RB, Shajahan AN, Klimach U, Wang A, Crawford AC, Zhu Y, Zwart A, Wang M and Clarke R: Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J 21: 4013-4027, 2007.
55. Healy SJM, Gorman AM, Mousavi-Shafaei P, Gupta S and Samali A: Targeting the endoplasmic reticulum-stress response as an anticancer strategy. Eur J Pharmacol 625: 234-246, 2009.
56. Gupta S, McGrath B and Cavener DR: PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice. PloS One 4: e8008, 2009.
57. Ranganathan AC, Ojha S, Kourtidis A, Conklin DS and Aguirre-Ghiso JA: Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival. Cancer Res 68: 3260-3268, 2008.
58. Sequeira SJ, Ranganathan AC, Adam AP, Iglesias BV, Farias EF and Aguirre-Ghiso JA: Inhibition of proliferation by PERK regulates mammary acinar morphogenesis and tumor formation. PloS One 2: e615, 2007.
59. Perkins DJ and Barber GN: Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts. Mol Cell Biol 24: 2025-2040, 2004.
60. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP and Ron D: CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18: 3066-3077, 2004.
61. Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, Yuan CL, Krokowski D, Wang S, Hatzoglou M, Kilberg MS, Sartor MA and Kaufman RJ: ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nature Cell Biol 15: 481-490, 2013.
62. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D and Yuan J: A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307: 935-939, 2005.
63. Gorman AM, Healy SJM, Jäger R and Samali A: Stress management at the ER: Regulators of ER stress-induced apoptosis. Pharmacol Ther 134: 306-316, 2012.
64. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL and Ron D: CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12: 982-995, 1998.
65. Jauhiainen A, Thomsen C, Strömbom L, Grundevik P, Andersson C, Danielsson A, Andersson MK, Nerman O, Rörkvist L, Ståhlberg A and Aman P: Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153. PloS One 7: e33208, 2012.
66. Weston RT and Puthalakath H: Endoplasmic reticulum stress and BCL-2 family members. Adv Exp Med Biol 687: 65-77, 2010.
67. Li G, Mongillo M, Chin KT, Harding H, Ron D, Marks AR and Tabas I: Role of ERO1-α-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol 186: 783-792, 2009.
68. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME and Tabas I: Calcium/calmodulin-dependent protein kinase II links ER stress with FAS and mitochondrial apoptosis pathways. J Clin Invest 119: 2925-2941, 2009.
69. Nishitoh H: CHOP is a multifunctional transcription factor in the ER stress response. J Biochem 151: 217-219, 2012.
70. Verma G and Datta M: The critical role of JNK in the ER-mitochondrial crosstalk during apoptotic cell death. J Cell Physiol 227: 1791-1795, 2012.
71. Nakagawa H, Hirata Y, Takeda K, Hayakawa Y, Sato T, Kinoshita H, Sakamoto K, Nakata W, Hikiba Y, Omata M, Yoshida H, Koike K, Ichijo H and Maeda S: Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase. Hepatology 54: 185-195, 2011.
72. Kim I, Shu CW, Xu W, Shiau CW, Grant D, Vasile S, Cosford NDP and Reed JC: Chemical biology investigation of cell death pathways activated by endoplasmic reticulum stress reveals cytoprotective modulators of ASK1. J Biol Chem 284: 1593-1603, 2009.
73. Weston CR and Davis RJ: The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149, 2007.
74. Puthalakath H, O'Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND, Hughes PD, Michalak EM, McKimm-Breschkin J, Motoyama N, Gotoh T, Akira S, Bouillet P and Strasser A: ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129: 1337-1349, 2007.
75. Pike LRG, Phadwal K, Simon AK and Harris AL: ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia. Mol Biol Rep 39: 10811-10822, 2012.
76. Hetz C, Bernasconi P, Fisher J, Lee AH, Bassik MC, Antonsson B, Brandt GS, Iwakoshi NN, Schinzel A, Glimcher LH and Korsmeyer SJ: Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1α. Science 312: 572-576, 2006.
77. Klee M, Pallauf K, Alcalá S, Fleischer A and Pimentel-Muiños FX: Mitochondrial apoptosis induced by BH3-only molecules in the exclusive presence of endoplasmic reticular Bak. EMBO J 28: 1757-1768, 2009.
78. Lisbona F, Rojas-Rivera D, Thielen P, Zamorano S, Todd D, Martinon F, Glavic A, Kress C, Lin JH, Walter P, Reed JC, Glimcher LH and Hetz C: BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1á. Mol Cell 33: 679-691, 2009.
79. 2+-permeable channel pore. J Biol Chem 287: 2544-2557, 2012.
80. Zong WX, Li C, Hatzivassiliou G, Lindsten T, Yu QC, Yuan J and Thompson CB: Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 162: 59-69, 2003.
81. Lee AS: GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67: 3496-3499, 2007.
82. 2+: A control point for apoptosis. Science 300: 135-139, 2003.
83. Morishima N, Nakanishi K and Nakano A: Activating transcription factor-6 (ATF6) mediates apoptosis with reduction of myeloid cell leukemia sequence 1 (Mcl-1) protein via induction of WW domain binding protein 1. J Biol Chem 286: 35227-35235, 2011.
84. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K, Tsujimoto Y and Tohyama M: Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and amyloid-β-induced cell death. J Cell Biol 165: 347-356, 2004.
85. Tan Y, Dourdin N, Wu C, De Veyra T, Elce JS and Greer PA: Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J Biol Chem 281: 16016-16024, 2006.
86. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, Droin N, Ulevitch RJ, Green DR and Nicholson DW: Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 440: 1064-1068, 2006.
87. Li C, Wei J, Li Y, He X, Zhou Q, Yan J, Zhang J, Liu Y, Liu Y and Shu HB: Transmembrane protein 214 (TMEM214) mediates endoplasmic reticulum stress-induced caspase-4 activation and apoptosis. J Biol Chem 288: 17908-17917, 2013.
88. Axten JM, Medina JR, Feng Y, Shu A, Romeril SP, Grant SW, Li WHH, Heerding DA, Minthorn E, Mencken T, Atkins C, Liu Q, Rabindran S, Kumar R, Hong X, Goetz A, Stanley T, Taylor JD, Sigethy SD, Tomberlin GH, Hassell AM, Kahler KM, Shewchuk LM and Gampe RT: Discovery of 7-methyl-5-(1-{(3-(trifluoromethyl) phenyl)acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem 55: 7193-7207, 2012.
89. Flaherty DP, Golden JE, Liu C, Hedrick M, Gosalia P, Li Y, Milewski M, Sugarman E, Suyama E, Nguyen K, Vasile S, Salaniwal S, Stonich D, Su Y, Mangravita-Novo A, Vicchiarelli M, Smith LH, Diwan J, Chung TDY, Pinkerton AB, Aubé J, Miller JR, Garshott DM, Callaghan MU, Fribley AM and Kaufman RJ: Selective Small Molecule Activator of the Apoptotic Arm of the UPR. National Center for Biotechnology Information (US), Probe Reports, 1 April 2012.
90. Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM and Walter P: IRE1 signaling affects cell fate during the unfolded protein response. Science 318: 944-949, 2007.
91. Ji C: Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries. Biochem Res Int 2012: 216450, 2012.
92. Teodoro T, Odisho T, Sidorova E and Volchuk A: Pancreatic β-cells depend on basal expression of active ATF6α-p50 for cell survival even under nonstress conditions. Am J Physiol Cell Physiol 302: C992-C1003, 2012.
93. Yamaguchi Y, Larkin D, Lara-Lemus R, Ramos-Castañeda J, Liu M and Arvan P: Endoplasmic reticulum (ER) chaperone regulation and survival of cells compensating for deficiency in the ER stress response kinase, PERK. J Biol Chem 283: 17020-17029, 2008.